These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26718019)

  • 1. Long-Term Effects of Renal Sympathetic Denervation on Hypertensive Patients With Mild to Moderate Chronic Kidney Disease.
    Kiuchi MG; Graciano ML; Carreira MA; Kiuchi T; Chen S; Lugon JR
    J Clin Hypertens (Greenwich); 2016 Mar; 18(3):190-6. PubMed ID: 26718019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in albumin-to-creatinine ratio at 12-month follow-up in patients undergoing renal denervation.
    Sousa H; Branco P; de Sousa Almeida M; de Araújo Gonçalves P; Gaspar A; Dores H; Mesquita J; Andrade MJ; Neuparth N; Aleixo A; Mendes M; Barata JD
    Rev Port Cardiol; 2017 May; 36(5):343-351. PubMed ID: 28456548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
    Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
    Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal denervation on end organ damage in hypertensive patients.
    Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M; Leiner T
    Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.
    Krum H; Schlaich M; Whitbourn R; Sobotka PA; Sadowski J; Bartus K; Kapelak B; Walton A; Sievert H; Thambar S; Abraham WT; Esler M
    Lancet; 2009 Apr; 373(9671):1275-81. PubMed ID: 19332353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
    Lambert T; Blessberger H; Gammer V; Nahler A; Grund M; Kerschner K; Buchmayr G; Saleh K; Kammler J; Steinwender C
    Clin Cardiol; 2014 May; 37(5):307-11. PubMed ID: 24700288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal sympathetic denervation in patients with hypertension and chronic kidney disease: does improvement in renal function follow blood pressure control?
    Kiuchi MG; Chen S; Andrea BR; Kiuchi T; Carreira MA; Graciano ML; Lugon JR
    J Clin Hypertens (Greenwich); 2014 Nov; 16(11):794-800. PubMed ID: 25293878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.
    Courand PY; Pereira H; Del Giudice C; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Vehier C; Lantelme P; Denolle T; Dourmap C; Halimi JM; Girerd X; Rossignol P; Zannad F; Ormezzano O; Vaisse B; Herpin D; Ribstein J; Bouhanick B; Mourad JJ; Ferrari E; Chatellier G; Sapoval M; Azarine A; Azizi M;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
    Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
    Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
    Kiuchi MG; Chen S
    Int J Cardiol; 2016 Nov; 223():494-496. PubMed ID: 27544613
    [No Abstract]   [Full Text] [Related]  

  • 14. Proof of concept study: Improvement of echocardiographic parameters after renal sympathetic denervation in CKD refractory hypertensive patients.
    Kiuchi MG; Mion D; Graciano ML; de Queiroz Carreira MA; Kiuchi T; Chen S; Lugon JR
    Int J Cardiol; 2016 Mar; 207():6-12. PubMed ID: 26788816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG; Tsioufis CP; Worthley MI; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Papademetriou V
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Cremers B; Janker J; Link B; Vonend O; Ukena C; Linz D; Schmieder R; Rump LC; Kindermann I; Sobotka PA; Krum H; Scheller B; Schlaich M; Laufs U; Böhm M
    Hypertension; 2012 Aug; 60(2):419-24. PubMed ID: 22733462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation.
    Singh RR; McArdle ZM; Iudica M; Easton LK; Booth LC; May CN; Parkington HC; Lombardo P; Head GA; Lambert G; Moritz KM; Schlaich MP; Denton KM
    Hypertension; 2019 Mar; 73(3):718-727. PubMed ID: 30661475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic denervation: early impact on ambulatory resistant hypertension.
    Schwerg M; Heupel C; Strajnic D; Baumann G; Laule M; Stangl V; Stangl K
    J Clin Hypertens (Greenwich); 2014 Jun; 16(6):406-11. PubMed ID: 24766570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.